Meshalkin National Medical Research Center is a research and hospital institution in Sovetsky District of Novosibirsk, Russia. It was founded in 1957. The organisation is one of the largest Russian hospital for the treatment of cardiovascular diseases.

During the past decade, E. Meshalkin National Medical Research Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "E. Meshalkin National Medical Research Center" #1 sponsor was "Meshalkin Research Institute of Pathology of Circulation" with 9 trials, followed by "Population Health Research Institute" with 4 trials sponsored, "Actelion" with 2 trials sponsored, "Erasmus Medical Center" with 1 trials sponsored and "Federal Research Clinical Center of Federal Medical & Biological Agency, Russia" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "E. Meshalkin National Medical Research Center" #1 collaborator was "Chelyabinsk Regional Clinical Hospital" with 1 trials as a collaborator, "Clinical Evaluation Research Unit at Kingston General Hospital" with 1 trials as a collaborator, "Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health" with 1 trials as a collaborator, "Hamilton Health Sciences Corporation" with 1 trials as a collaborator and "Heart and Vascular Center Bad Bevensen, Germany" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "E. Meshalkin National Medical Research Center" are "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Hypertrophic Obstructive Cardiomyopathy" (2 trials), "Arterial Thrombosis" (1 trials), "Asymptomatic Patients (Stenosis ≥80%)" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "E. Meshalkin National Medical Research Center" in a lesser frequency.

Most popular intervention types in "E. Meshalkin National Medical Research Center" are "Drug" (7 trials), "Procedure" (5 trials), "Diagnostic Test" (3 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tranexamic Acid" (2 trials), "Emboshield NAV6™" (1 trials), "Esmolol" (1 trials) and "High power ablation" (1 trials). Other intervention names were less common.

The vast majority of trials in "E. Meshalkin National Medical Research Center" are 18 trials for "All" genders.

Currently, there are NaN active trials in "E. Meshalkin National Medical Research Center". 2 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in E. Meshalkin National Medical Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in E. Meshalkin National Medical Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".